sotorasib
amgen
['sclc', 'lcsm,(-blcsm)', 'lung', 'codebreak201', 'sotorasib', 'nsclc', 'award']
 , recipient of 2020 cda award from lungevity, presents a poster recruiting for codebreak201, a phase 2 trial of sotorasib in krasg12c nsclc. currently enrolling. #asco22 #lcsm #nsclc 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.